Welcome to our dedicated page for DAVITA SEC filings (Ticker: DVA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DaVita Inc. filings document the operating results, governance and capital structure of a public kidney care and dialysis services company. Its 8-K reports furnish quarterly financial results, including revenue, operating income, per-share results, cash flow measures, treatment economics and share repurchase activity.
Proxy filings cover board matters, executive compensation, shareholder voting items and governance disclosures. Other current reports record material financing arrangements, amendments to secured credit facilities, share repurchase authorizations and the company's common stock listing on the New York Stock Exchange under DVA.
Moore Gregory J. reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. director Gregory J. Moore received an equity award of 332 shares of Common Stock on March 15, 2026. The shares were granted at no cash cost per share, indicating a compensation-related award rather than an open-market purchase. Following this grant, Moore directly holds 7,563 DaVita shares.
DaVita Inc. Chief Legal & Public Affairs Officer Kathleen Alyce Waters reported equity compensation grants and related tax withholdings. She received 8,610 stock appreciation rights tied to an equal number of common shares at an exercise price of $150.72 per share, scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030, subject to award terms. She also acquired 3,185 restricted stock units that are scheduled to vest on the same dates.
To cover tax obligations from the vesting of previously granted performance stock units and restricted stock units, 33,863 shares of common stock were withheld at $150.72 per share through several F-code transactions. Following these compensation-related grants and withholdings, Waters directly holds 124,599 shares of DaVita common stock.
DaVita Inc.’s Chief Compliance Officer, James O. Hearty, reported equity compensation and related tax withholding transactions. He received a grant of 3,050 stock appreciation rights tied to Common Stock at an exercise price of $150.72 per share, scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030.
He also acquired 1,128 shares of Common Stock as a share-based award, with the related restricted stock units scheduled to vest 50% on March 15, 2029 and 50% on March 15, 2030. In separate transactions, a total of 11,578 shares of Common Stock were withheld at $150.72 per share to satisfy tax withholding obligations upon vesting of performance stock units and earlier restricted stock units. After these compensation and tax-withholding entries, Hearty directly holds 38,137 shares of DaVita Common Stock.
DaVita Inc. director Wendy Lee Schoppert received a compensation-related stock award. On March 15, 2026, she acquired 332 shares of DaVita common stock with no purchase price, reported as a grant or similar award. Following this award, she directly held 332 shares and indirectly held 3,305 shares through the Wendy L. Schoppert Revocable Trust.
HEARTY JAMES O reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. reported that Chief Compliance Officer James O. Hearty received two non-derivative grants of common stock on March 10, 2026, comprising 1,756 shares and 20,533 shares, delivered upon satisfaction of criteria for earlier performance stock unit awards granted in 2022 and 2023 that are scheduled to vest 100% on March 15, 2026.
After these awards, he directly holds 48,587 shares of DaVita common stock.
ACKERMAN JOEL reported acquisition or exercise transactions in this Form 4 filing.
DaVita Inc. insider filing shows equity awards to its CFO. Joel Ackerman, CFO and Treasurer of DaVita Inc., received two grants of common stock, covering 6,585 and 65,997 shares at no cost, as part of performance stock unit awards. These shares relate to performance stock units granted on March 15, 2022 and March 15, 2023, of which 100% will vest on March 15, 2026. Following these awards, he directly holds 221,019 shares of DaVita common stock.
DaVita Inc. Chief Legal & Public Affairs Officer Kathleen Alyce Waters reported two stock awards of common shares. On March 10, 2026, she acquired 4,829 shares of DaVita common stock at a price of $0.00 per share and separately acquired 51,330 additional shares, also at $0.00 per share.
Footnotes explain these shares were received upon satisfaction of criteria for performance stock units granted on March 15, 2022 and March 15, 2023, with 100% of each award scheduled to vest on March 15, 2026. Following these acquisitions, Waters directly holds 155,277 shares of DaVita common stock.
DaVita Inc.’s Chief Legal & Public Affairs Officer, Kathleen Alyce Waters, reported several transactions on February 6, 2026. She exercised 8,079 Stock Appreciation Rights at an exercise price of $108.93, receiving the same number of common shares.
On the same date, she disposed of 5,898 shares of common stock at $149.22, and 817 shares were withheld to cover tax obligations related to the Stock Appreciation Rights exercise. After these transactions, she directly owned 99,118 shares of DaVita common stock.
DaVita Inc. CFO Joel Ackerman reported multiple equity transactions on February 6, 2026. He exercised 44,065 Stock Appreciation Rights at an exercise price of $108.93, receiving the same number of DaVita common shares. He then sold 32,168 common shares at $149.22 and had 5,100 shares withheld to cover tax obligations tied to the option exercise. After these transactions, he directly owned 148,437 DaVita common shares.